Invesaro

Stocks GRCE Earnings

Earnings

Grace Therapeutics, Inc. (GRCE) earnings

Quarterly results of Grace Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when GRCE files with the SEC.

Next earnings date

Grace Therapeutics, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q1 FY2027

In Q1 FY2027 (ended June 30, 2026) Grace Therapeutics, Inc. reported revenue of - and a net loss of $15.8M.

Diluted earnings per share were -$0.91.

Filed with the SEC on August 13, 2026.

Net income by quarter
Q2 25: -$3.4M -$3.4M Q2 25Q3 25: -$4.2M -$4.2M Q3 25Q4 25: $636K $636K Q4 25Q1 26: -$3.4M -$3.4M Q1 26Q2 26: -$938K -$938K Q2 26Q3 26: -$2.3M -$2.3M Q3 26Q4 26: -$1.2M -$1.2M Q4 26Q1 27: -$15.8M -$15.8M Q1 27

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q1 FY2027June 30, 2026---$15.8M-$0.91
Q4 FY2026March 31, 2026---$1.2M-
Q3 FY2026December 31, 2025---$2.3M-$0.14
Q2 FY2026September 30, 2025---$938K-$0.06
Q1 FY2026June 30, 2025---$3.4M-$0.21
Q4 FY2025March 31, 2025--$636K-
Q3 FY2025December 31, 2024---$4.2M-$0.36
Q2 FY2025September 30, 2024---$3.4M-$0.30

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Grace Therapeutics, Inc.'s next earnings date?

Grace Therapeutics, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Get an email when GRCE reports

Follow GRCE and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when GRCE files with the SEC.

Source: quarterly figures Grace Therapeutics, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Grace Therapeutics, Inc.